GroundRules
Browse New Mexico
Read the original sections, or search by topic.
- 26-1-3.2 · Prescription drug donation.
- 26-1-4 · Power to enjoin violations.
- 26-1-5 · Penalty; exemptions.
- 26-1-6 · Detection of drugs, devices or cosmetic believed adulterated, misbranded or counterfeit; condemnation; destruction or correction of defect; forfeiture and sale.
- 26-1-7 · Attorney general or district attorney to institute prosecutions.
- 26-1-8 · Minor violations of act; warnings authorized.
- 26-1-9 · Addition of poisonous or deleterious substances; color additives.
- 26-1-10 · Drug or device adulteration.
- 26-1-11 · Drug or device; misbranding.
- 26-1-12 · False advertising.
- 26-1-13 · Packaging and labeling requirements; proprietary preparations.
- 26-1-14 · New drugs and devices; prerequisites to sale, delivery or giving away; exceptions.
- 26-1-15 · Dangerous drugs; veterinary use; limitations.
- 26-1-16 · Dangerous drugs; conditions for sale; prescription refilling; limitations.
- 26-1-16.1 · Opioids; requiring practitioners to obtain and review reports from the prescription monitoring program.
- 26-1-17 · Testing laboratory.
- 26-1-18 · Promulgating regulations; procedure.
- 26-1-18.1 · Prescription drug prior authorization protocols.
- 26-1-19 · Power to make inspections and secure samples.
- 26-1-20 · Personnel.
- 26-1-21 · Power of board to publish reports and disseminate information.
- 26-1-22 · Unlawful means of obtaining dangerous drugs enumerated.
- 26-1-23 · False statements; false pretenses; forgery of labels or prescriptions prohibited.
- 26-1-24 · Cosmetics; misbranding.
- 26-1-25 · Cosmetics; adulteration.
- 26-1-26 · Penalties.
- 26-1-27 · Prohibition of discrimination against 340B entities.
- 26-2-1 · 26-2-1 to 26-2-4. Repealed.
- 26-2-4.1 · Recompiled.
- 26-2-5 · 26-2-5 to 26-2-14. Repealed.
- 26-2A-1 · Short title.
- 26-2A-2 · Purpose.
- 26-2A-3 · Definitions.
- 26-2A-4 · Lynn Pierson therapeutic research program established; participation.
- 26-2A-5 · Patient qualification review board; composition; powers and duties.
- 26-2A-6 · Lynn Pierson therapeutic research program; distribution.
- 26-2A-7 · Report.
- 26-2B-1 · Short title.
- 26-2B-2 · Purpose of act.
- 26-2B-3 · Definitions.
- 26-2B-4 · Exemption from criminal and civil penalties for the medical use of cannabis.
- 26-2B-5 · Prohibitions, restrictions and limitations on the medical use of cannabis; criminal penalties.
- 26-2B-6 · Advisory board created; duties.
- 26-2B-6.1 · Assessment reporting.
- 26-2B-7 · Registry identification cards; department rules; duties; reciprocity.
- 26-2B-7.1 · Registry identification card; registration; renewal; written certification.
- 26-2B-8 · THC content; no limitation.
- 26-2B-9 · Employment protections.
- 26-2B-10 · Persons under state supervision; protections.
- 26-2C-1 · Short title.
- 26-2C-2 · Definitions.
- 26-2C-3 · Division; powers and duties; rulemaking; advisory committee created; membership; duties.
- 26-2C-3.1 · Criminal history background checks; processes and procedures.
- 26-2C-4 · Department of health; duties; public health and safety advisory committee.
- 26-2C-5 · Department of health; duties; transfer of licensing duties.
- 26-2C-6 · Licensing cannabis activities; limitations; medical cannabis legacy licensing; cannabis shortage for medical program; conversion of nonprofit medical cannabis corporations.
- 26-2C-7 · Cannabis activity licensing; application; issuance and denial of a license; suspension and revocation.
- 26-2C-8 · Licensees; disciplinary actions; sanctions; civil penalty.
- 26-2C-9 · Application and licensing fees.
- 26-2C-10 · Cannabis training and education programs; registration with division.
- 26-2C-11 · Cannabis server permits; cannabis servers; permit required; applications; education program approval required; issuance or denial of a permit or approval; penalties.
- 26-2C-12 · Local control.
- 26-2C-13 · Licensee protections.
- 26-2C-14 · Protection of underage persons; providing cannabis products to minors; penalties.
- 26-2C-15 · Transport via courier.
- 26-2C-16 · Packaging and labeling.
- 26-2C-17 · Cannabis products; packaging and labeling; division rulemaking.
- 26-2C-17.1 · When cannabis deemed misbranded.
- 26-2C-18 · Testing cannabis products; health and safety of employees and consumers.
- 26-2C-18.1 · When cannabis product deemed adulterated.
- 26-2C-19 · Researching cannabis; recordkeeping.
- 26-2C-20 · Advertising and marketing restrictions.
- 26-2C-21 · Contracts.
- 26-2C-22 · Provision of professional services.
- 26-2C-23 · Medical cannabis provisions unaffected.
- 26-2C-24 · Protections for the use of cannabis.
- 26-2C-25 · Personal use of cannabis.
- 26-2C-26 · Limits on personal use; penalties.
- 26-2C-27 · Personal production of cannabis; penalties.
- 26-2C-28 · Trafficking cannabis products; penalties.
- 26-2C-29 · Cannabis within restricted area; penalty.
- 26-2C-30 · Unlawful possession of cannabis; penalties.
- 26-2C-31 · Unlicensed manufacturing of cannabis extract; penalty.
- 26-2C-32 · Exemption from criminal and civil penalties; researchers.
- 26-2C-33 · Reporting requirements for cannabis-related violations.
- 26-2C-34 · Employer protections; exemptions.
- 26-2C-35 · Appeal of rules.
- 26-2C-36 · Public records and open meetings.
- 26-2C-37 · Intrastate source.
- 26-2C-38 · Imports and exports.
- 26-2C-39 · Cannabis regulation fund.
- 26-2C-40 · Plant limit.
- 26-2C-41 · Indian nations, tribes and pueblos; intergovernmental agreements.
- 26-2C-42 · Cooperation of agencies.
- 26-2C-43 · Enforcement; division and enforcement bureau; orders restricting movement of goods; embargo and recall, seizure and condemnation; procedures; penalties.
- 26-2D-1 · Short title.
- 26-2D-2 · Purpose of act.
- 26-2D-3 · Definitions.
- 26-2D-4 · Applicability.
- 26-2D-5 · Exemption from criminal and civil penalties for the medical use of psilocybin.